Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
TAG Oil prepares for flow testing of its first unconventional oil well in Egypt (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News 9 Meters Biopharma Inc NMTRQ

Healthcare
9 Meters Biopharma, Inc. has ceased operations. The Company has filed a voluntary petition for relief under provisions of Chapter 7 of Title 11 of the United States Code (the Bankruptcy Code) in the United States Bankruptcy Court for the Eastern District of North Carolina.

Recent & Breaking News (GREY:NMTRQ)

9 Meters Biopharma Announces Management Change and Provides Clinical Update on Vurolenatide in Patients with Short Bowel Syndrome

Accesswire May 30, 2023

9 Meters Biopharma Provides Business Update and Reports Financial Results for First Quarter 2023

Accesswire May 15, 2023

9 Meters Biopharma Announces Successful Pre-IND Meeting with FDA Regarding Its GIP Antagonist NM-136 for Obesity

Accesswire April 5, 2023

9 Meters Biopharma Provides Business Update and Reports Financial Results for Fourth Quarter and Full Year 2022

Accesswire March 28, 2023

9 Meters Biopharma Announces Closing of $5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Accesswire March 15, 2023

9 Meters Biopharma Announces $5 Million Registered Direct Offering Priced at-the-Market Under Nasdaq Rules

Accesswire March 14, 2023

9 Meters Biopharma to Present at the Oppenheimer 33rd Annual Healthcare Conference

Accesswire March 7, 2023

9 Meters Biopharma to Present at the 2023 BIO CEO & Investor Conference

Accesswire January 31, 2023

9 Meters Biopharma Announces Phase 3 Study of Vurolenatide in Short Bowel Syndrome

Accesswire November 29, 2022

9 Meters Biopharma Announces Continued Immuno-Oncology Collaboration with Gustave Roussy

Accesswire November 14, 2022

9 Meters Biopharma Provides Business Update and Reports Financial Results for Third Quarter 2022

Accesswire November 8, 2022

9 Meters Biopharma Presents Preclinical Data on Glucose-Dependent Insulinotropic Polypeptide (GIP) Monoclonal Antibodies for Obesity at the American College of Gastroenterology 2022 Annual Scientific Meeting

Accesswire October 24, 2022

9 Meters Biopharma to Present at the American College of Gastroenterology (ACG) 2022 Annual Scientific Meeting

Accesswire October 18, 2022

9 Meters Biopharma Announces 1-for-20 Reverse Stock Split

Accesswire October 17, 2022

9 Meters Biopharma Announces Positive Final Results from Phase 2 VIBRANT Study and Successful End-of-Phase 2 Meeting with FDA for Vurolenatide in Short Bowel Syndrome

Accesswire September 26, 2022

9 Meters Biopharma to Present at the H.C. Wainwright 24th Annual Global Investment Conference

Accesswire September 6, 2022

9 Meters Biopharma to Participate at the 44th European Society for Clinical Nutrition and Metabolism (ESPEN) Congress

Accesswire September 1, 2022

9 Meters Biopharma to Participate in the Citi 17th Annual BioPharma Conference

Accesswire August 31, 2022

9 Meters Biopharma Provides Business Update and Reports Financial Results for Second Quarter 2022

Accesswire August 15, 2022

9 Meters Biopharma to Participate in the William Blair Biotech Focus Conference 2022

Accesswire July 6, 2022